Association of the Microsatellite in the 3' Untranslated Region of the CD154 Gene with Rheumatoid Arthritis in Females from a Spanish Cohort: a Case-control Study
Overview
Authors
Affiliations
CD40-CD154 interaction is an important mediator of inflammation and has been implicated in T helper type 1-mediated autoimmune diseases including rheumatoid arthritis (RA). Linkage studies have shown association of markers in the proximity of the CD154 gene. In the present work we investigated whether specific allele variants of the microsatellite in the 3' UTR of the CD154 gene might modulate the risk of RA. The study, in a case-control setting, included 189 patients and 150 healthy controls from the Canary Islands, Spain. The 24CAs allele was less represented in female patients than in controls (0.444 in controls versus 0.307 in patients, P = 0.006, odds ratio (OR) 0.556, 95% confidence interval (CI) 0.372 to 0.831) but not in males (0.414 versus 0.408), and only when homozygous (P = 0.012; OR 0.35, 95% CI 0.16 to 0.77). We also verified that CD154 association with RA was independent of human leukocyte antigen (HLA) phenotype. A further functional study showed that after stimulation anti-CD3, CD154 mRNA was more stable in CD4+ T lymphocytes from patients with RA bearing the 24CAs allele (mRNA half-life 208 minutes) than in patients without the 24CAs allele (109 minutes, P = 0.009). However, a lower percentage of CD154+CD4+ T lymphocytes was seen in freshly isolated peripheral blood mononuclear cells from patients carrying 24CAs alleles (mean 4.28 versus 8.12; P = 0.033), and also in CD4+ T lymphocytes stimulated with anti-CD3 (median 29.40 versus 47.60; P = 0.025). These results were concordant with the smaller amounts of CD154 mRNA isolated from stimulated T lymphocytes with 24CAs alleles. The CD154 microsatellite therefore seems to affect the expression of the gene in a complex manner that implies not only mRNA stability. These data suggest that the CD154 microsatellite contributes to the regulation of mRNA and protein expression, although further studies will be necessary to elucidate its role in disease predisposition.
Shi Y, Jiang Z, Jiang L, Xu J Sci Rep. 2021; 11(1):14153.
PMID: 34239024 PMC: 8266822. DOI: 10.1038/s41598-021-93789-2.
Roman-Fernandez I, Sanchez-Zuno G, Padilla-Gutierrez J, Cerpa-Cruz S, Hernandez-Bello J, Valle Y Clin Rheumatol. 2017; 37(2):345-353.
PMID: 28963582 DOI: 10.1007/s10067-017-3853-9.
Levels of human platelet-derived soluble CD40 ligand depend on haplotypes of CD40LG-CD40-ITGA2.
Aloui C, Prigent A, Tariket S, Sut C, Fagan J, Cognasse F Sci Rep. 2016; 6:24715.
PMID: 27094978 PMC: 4837387. DOI: 10.1038/srep24715.
Wu H, Gaur U, Mekchay S, Peng X, Li L, Sun H J Appl Genet. 2015; 56(4):481-491.
PMID: 25737137 DOI: 10.1007/s13353-015-0275-8.
Are polymorphisms of the immunoregulatory factor CD40LG implicated in acute transfusion reactions?.
Aloui C, Sut C, Prigent A, Fagan J, Cognasse F, Granados-Herbepin V Sci Rep. 2014; 4:7239.
PMID: 25430087 PMC: 5384113. DOI: 10.1038/srep07239.